ANDRE JUICE (02218): Completion of Delivery for Acquisition of Control over Ningbo Yongqiang Technology
ANDRE JUICE (02218) announced that Yantai North Andre Juice Co., Ltd. (hereinafter referred to as the "Company") held the 10th meeting of the ninth Board of Directors on June 15, 2026, at which the proposal on signing the Equity Transfer Framework Agreement was deliberated and approved, agreeing that the Company would acquire part of the equity of Ningbo Yongqiang Technology Co., Ltd. (hereinafter referred to as "Yongqiang Technology") using its own funds or self-raised funds.
ANDRE JUICE (02218) issued an announcement that Yantai North ANDRE JUICE Co., Ltd. (hereinafter referred to as the "Company") held the tenth meeting of the ninth board of directors on June 15, 2026, at which it deliberated and approved the "Proposal on Signing the Equity Transfer Framework Agreement," agreeing that the Company would acquire part of the equity of Ningbo Yongqiang Technology Co., Ltd. (hereinafter referred to as "Yongqiang Technology") using its own funds or self-raised funds.
On September 18, 2026, the Company held the twelfth meeting of the ninth board of directors and deliberated and approved the "Proposal on the Proposed Acquisition of Control over Ningbo Yongqiang Technology Co., Ltd. and Signing of the Equity Transfer Agreement." The board of directors unanimously agreed that the Company would acquire 62.0611% of the equity of Yongqiang Technology for RMB792,787,965.88 using its own funds or self-raised funds.
As of the disclosure date of this announcement, the matter of this acquisition of control over Yongqiang Technology has been completed. The Company has completed the relevant equity delivery and payment arrangements as agreed in the agreement. The 62.0611% equity interest in Yongqiang Technology has been registered under the Company's name, and the industrial and commercial change registration procedures have been completed. Yongqiang Technology has become a controlled subsidiary of the Company and has been included in the scope of the Company's consolidated financial statements from the date of completion of the industrial and commercial change registration. The board of directors of Yongqiang Technology has also completed its change of term, and the Company has nominated 3 directors and obtained a majority of seats on the board of directors, enabling it to exercise effective control over Yongqiang Technology.
Related Articles

SUNAC SERVICES (01516) repurchased 300,000 shares on October 27 for approximately HK$206,600.

CHINARES PHARMA (03320): China Resources Double-Crane Pharmaceutical's net profit for the first three quarters was approximately RMB1.307 billion, a year-on-year decrease of 6.51%.

BASICSEMI (09971) repurchased 20,000 shares for HK$658,900 on October 27.
SUNAC SERVICES (01516) repurchased 300,000 shares on October 27 for approximately HK$206,600.

CHINARES PHARMA (03320): China Resources Double-Crane Pharmaceutical's net profit for the first three quarters was approximately RMB1.307 billion, a year-on-year decrease of 6.51%.

BASICSEMI (09971) repurchased 20,000 shares for HK$658,900 on October 27.






